Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/1995
10/11/1995EP0675760A1 Method and apparatus for creating biopolymer arrays on a solid support surface
10/11/1995CN1029989C Method for preparing the xenogeneic albumen from streptomyces
10/10/1995US5457195 Sapphyrin derivatives and conjugates
10/10/1995US5457191 3-deazapurines
10/10/1995US5457189 Antisense oligonucleotide inhibition of papillomavirus
10/10/1995US5457187 Oligonucleotides containing 5-fluorouracil
10/10/1995US5457183 Radiosensitizers
10/10/1995US5457089 Muteins of human erythropoietin, the preparation thereof and the use thereof
10/10/1995US5457049 Tumor suppressor protein pRb2, related gene products, and DNA encoding therefor
10/10/1995US5457047 DNA Sequences coding for PTH variants, PTH variants, expression vector, bacterial host, use and therapeutic composition
10/10/1995US5457033 Producing polypeptide with methionine residue at amino end and glycine residue at carboxyl end by recombinant DNA methods, enzymatically cleaving to polypeptide carboxamide
10/10/1995CA1337278C Activated rnase l as a marker for viral infections
10/05/1995WO1995026412A1 Ligands added to adenovirus fiber
10/05/1995WO1995026409A1 RECOMBINANT ADENOVIRUSES CODING FOR BASIC FIBROBLAST GROWTH FACTORS (bFGF)
10/05/1995WO1995026408A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf)
10/05/1995WO1995026361A1 Vpr AND Vpx PROTEINS OF HIV
10/05/1995WO1995026200A1 Enhanced virus-mediated dna transfer
10/05/1995WO1995026199A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand
10/05/1995WO1995026196A1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON
10/05/1995WO1995026190A1 Novel anti-hiv drug
10/05/1995CA2186856A1 Chimeric infectious bursal disease virus cdna clones, expression products and vaccines based thereon
10/05/1995CA2186496A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand
10/05/1995CA2186398A1 Vpr and vpx proteins of hiv
10/05/1995CA2184755A1 Recombinant adenoviruses coding for basic fibroblast growth factors (bfgf)
10/04/1995EP0675201A1 Compositions and methods for stimulating megakaryocyte growth and differentiation
10/04/1995EP0675136A2 Antibodies to mammalian interleukin-4 and peptides useful as antigens in their production
10/04/1995EP0674714A1 Recombinant canine gastric lipase and pharmaceutical compositions
10/04/1995EP0674712A1 A proteinase inhibitor, precursor thereof and genetic sequences encoding same
10/04/1995EP0674707A1 Compounds and methods for the treatment of leukemias
10/04/1995EP0674705A1 Antisense oligonucleotides to inhibit expression of mutated and wild type genes for collagen
10/04/1995EP0674660A1 Multifunctional neurotrophic factors
10/04/1995EP0674657A1 Gp41 mutants and their use as hiv therapeutics
10/04/1995EP0674650A1 Nucleic acid probes for lactobacillus detection
10/04/1995EP0674647A1 Analytical technique for oligonucleotide analogs.
10/04/1995CN1109505A Interferon-alpha/beta binding protein, its preparation and use
10/03/1995US5455329 DNA sequences coding for PTH variants, PTH variants, expression vector, bacterial host, use and therapeutic composition
10/03/1995US5455233 Detectors, antiinflammatory, antilipemic agents and antitumor agents
10/03/1995US5455157 Introducing nucleotide labelled with hapten into cell with addition of nonencapsulating cationic liposome, determining incorporation into nucleic acids as function of time
09/1995
09/28/1995WO1995025814A1 Oligonucleotide n3'→p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties
09/28/1995WO1995025813A1 Germline mutations in the mts gene and method for detecting predisposition to cancer at the mts gene
09/28/1995WO1995025809A1 Compacted nucleic acids and their delivery to cells
09/28/1995WO1995025808A1 Process for treating eucaryotic cells
09/28/1995WO1995025806A2 Packaging-deficient lentiviruses
09/28/1995WO1995025805A1 Recombinant viruses coding for a glutamate decarboxylase (gad) activity
09/28/1995WO1995025804A1 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf)
09/28/1995WO1995025803A1 RECOMBINANT ADENOVIRUSES CODING FOR ACIDIC FIBROBLAST GROWTH FACTOR (aFGF)
09/28/1995WO1995025802A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-β)
09/28/1995WO1995025800A1 Gene-therapeutic process using antibiotic-resistance gene-free dna vectors
09/28/1995WO1995025795A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS
09/28/1995WO1995025792A1 Neuron promoter and uses
09/28/1995WO1995025788A1 Novel mutated viruses, anti-viral compounds and novel methods of making vaccines
09/28/1995WO1995025737A1 Method for identifying members of combinatorial libraries
09/28/1995WO1995025535A1 Thyroxin-binding proteins
09/28/1995WO1995025429A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence
09/28/1995WO1995023860A3 KUNITZ DOMAIN INHIBITOR PROTEINS DERIVED FROM ALZHEIMER'S AMYLOID β-PROTEIN PRECURSOR INHIBITOR
09/28/1995WO1995023855A3 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
09/28/1995CA2186242A1 Gene-therapeutic process using antibiotic-resistance gene-free dna vectors
09/28/1995CA2186035A1 Thyroxin-binding proteins
09/28/1995CA2185788A1 Neuron promoter and uses
09/28/1995CA2184409A1 Recombinant adenoviruses coding for acidic fibroblast growth factor (afgf)
09/28/1995CA2184408A1 Recombinant adenoviruses for glial maturation factor beta (gmf-.beta.)
09/28/1995CA2184200A1 Recombinant viruses, preparation and use in genic therapy
09/28/1995CA2183647A1 Process for treating eucaryotic cells
09/28/1995CA2162147A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence
09/27/1995EP0674176A1 Electrochemiluminescent rhenium moieties and methods of production
09/27/1995EP0674004A1 MSRV1 virus and pathogenic and/or infections agent MSRV2 linked to multiple sclerosis, their nucleic components and their applications
09/27/1995EP0673440A1 Mammalian muscle nad:arginine adp-ribosyltransferase
09/27/1995EP0673435A1 Synthetic unrandomization of oligomer fragments
09/27/1995EP0673431A1 Gene therapy for cystic fibrosis
09/27/1995EP0673426A1 Platelet-activating factor acetylhydrolase
09/27/1995EP0673421A1 Allergenic proteins and peptides from johnson grass pollen
09/27/1995EP0673420A1 Mammalian receptors for interleukin-10 (il-10)
09/27/1995EP0673382A1 METHODS AND COMPOSITIONS FOR cDNA SYNTHESIS
09/27/1995EP0673260A1 Formation of triple helix complexes using a novel motif
09/27/1995EP0673255A1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof
09/27/1995EP0673252A1 Administration of oligonucleotides antisense to dopamine receptor mrna for diagnosis and treatment of neurological pathologies
09/27/1995EP0665897A4 Complex combinatorial chemical libraries encoded with tags.
09/27/1995EP0593460B1 Method and apparatus for biopolymer synthesis
09/27/1995EP0261225B1 Lectin complex and method and probe for making same
09/27/1995CN1109260A A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector
09/26/1995US5453496 Polynucleotide phosphorodithioate
09/26/1995US5453361 Method for producing biologically active human brain derived neurotrophic factor
09/26/1995US5453355 Oligonucleotides and methods for the detection of Neisseria gonorrhoeae
09/21/1995WO1995025170A1 NOVEL MUTEINS OF IFN-$g(b)
09/21/1995WO1995025125A1 Dna encoding cai resistance proteins and uses thereof
09/21/1995WO1995025116A1 Method and apparatus for performing multiple sequential reactions on a matrix
09/21/1995WO1995025114A1 Plant peptide transport gene
09/21/1995WO1995025093A1 Acridone-derived bisintercalators as chemotherapeutic agents
09/21/1995WO1995024928A2 Heparin-binding growth factors for gene therapy and anterior eye disorders
09/21/1995WO1995024915A1 Product and process for regulating signal transduction pathways
09/21/1995CA2207851A1 Plant peptide transport gene
09/21/1995CA2185671A1 Heparin-binding growth factors for gene therapy and anterior eye disorders
09/21/1995CA2185341A1 Dna encoding cai resistance proteins and uses thereof
09/21/1995CA2184631A1 Product and process for regulating signal transduction pathways
09/21/1995CA2184589A1 Method and apparatus for performing multiple sequential reactions on a matrix
09/20/1995EP0672677A2 Polyamide-oligonucleotide derivatives, their production and use
09/20/1995EP0672418A2 Use of adenosine monophosphate deaminase inhibitor for increasing extracellular adenosine
09/20/1995EP0672193A1 Oligonucleotides having a conserved g 4? core sequence
09/20/1995EP0672191A1 Quantitative detection of macromolecules with fluorescent oligonucleotides
09/20/1995EP0672190A1 Formation of triple helix complexes of single stranded nucleic acids using nucleoside oligomers which comprise pyrimidine analogs